Ramanathan,
Hwang,
Zamboni,
Sinicrope,
Safran,
Wong,
Earle,
Brufsky,
Evans,
Troetschel,
Walko,
Day,
Chen,
Finkelstein,
- Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial. Ramanathan, R.K., Hwang, J.J., Zamboni, W.C., Sinicrope, F.A., Safran, H., Wong, M.K., Earle, M., Brufsky, A., Evans, T., Troetschel, M., Walko, C., Day, R., Chen, H.X., Finkelstein, S. Cancer Invest. (2004)